ALL HANDS ON DECK, NONE BEHIND BACK
After months of reports of relative "horror stories" emerging from FDA's device approval and review departments, the FDA will today hold a meeting to discuss these issues. The NYT report is at:
This should be the first test of whether the Obama FDA's leaders will respond differently to dissenting reviewers than more recent versions of the agency. It will certainly be interesting and important to follow.